Correlation of Systemic Inflammation Parameters and Serum SLFN11 in Small Cell Lung Cancer—A Prospective Pilot Study

202411 citationsJournal Articlegold Open Access

Authors

I. Simic · MSD (Serbia)

Azra Guzonjić · University of Belgrade

Jelena Kotur Stevuljević · University of Belgrade

Vesna Ćeriman Krstić · University of Belgrade

Natalija Samardžić

Katarina Savić Vujović · University of Belgrade

Dragana Jovanović · Grade Medical (Czechia)

Abstract

The combination of inflammatory markers and the levels of two specific proteins (sPD-L1, SLFN11) could potentially serve as a non-invasive biomarker for predicting responses to DNA-damaging therapeutic agents in SCLC.

Topics & Keywords

Lung Cancer Research Studies Inflammatory Biomarkers in Disease Prognosis PARP inhibition in cancer therapy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Biomedicines

Volume 12, Issue 5, pp. 976-976

DOI: 10.3390/biomedicines12050976

Field-Weighted Citation Impact: 3.25